Physician profile
Ricky E Collins
NPI 1659364024
$762.62
in general payments reported to CMS, 2019-2025
18 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.84 · 2020: $99.75 · 2021: $103 · 2023: $104 · 2024: $215 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $104.59 | 2024-2025 | Cologuard Collection Kit |
| Mallinckrodt Hospital Products INC. | $88.32 | 2020 | |
| Abbvie INC. | $68.07 | 2021-2024 | Mavyret |
| Lilly USA, LLC | $56.05 | 2021-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $51.39 | 2021 | |
| Novo Nordisk INC | $48.80 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Melinta Therapeutics, LLC | $46.77 | 2023-2025 | Kimyrsa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.33 | 2023-2024 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $42.84 | 2023-2024 | Nuzyra |
| Csl Behring | $41.27 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $38.20 | 2025 | Xacduro, Zevtera |
| Amgen INC. | $29.00 | 2024-2025 | Evenity, Prolia |
| Ultragenyx Pharmaceutical INC. | $21.72 | 2024 | Crysvita |
| Daiichi Sankyo INC. | $19.63 | 2024 | Injectafer |
| Boston Scientific Corporation | $18.03 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $15.25 | 2025 | Ponvory |
| Astrazeneca Pharmaceuticals LP | $14.96 | 2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $13.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.